Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.

[1]  Pierre Tufféry,et al.  BIOINFORMATICS ORIGINAL PAPER , 2022 .

[2]  M. Holick.  The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. , 2008, Molecular aspects of medicine.

[3]  A. Deacon,et al.  New paradigm for macromolecular crystallography experiments at SSRL: automated crystal screening and remote data collection , 2008, Acta crystallographica. Section D, Biological crystallography.

[4]  H. DeLuca.  Evolution of our understanding of vitamin D. , 2008, Nutrition reviews.

[5]  W. Liao,et al.  Studies of Membrane Topology of Mitochondrial Cholesterol Hydroxylases CYPs 27A1 and 11A1 , 2008, Lipids.

[6]  A. Muñoz,et al.  Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. , 2008, Anticancer research.

[7]  Eric F. Johnson,et al.  Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain , 2008, Proceedings of the National Academy of Sciences.

[8]  D. Moras,et al.  Structure-based design of a superagonist ligand for the vitamin D nuclear receptor. , 2008, Chemistry & biology.

[9]  M. Machius,et al.  Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel. , 2008, Biochemistry.

[10]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[11]  R. Stevens,et al.  Designing facial amphiphiles for the stabilization of integral membrane proteins. , 2007, Angewandte Chemie.

[12]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[13]  F. Guengerich.  Mechanisms of cytochrome P450 substrate oxidation: MiniReview , 2007, Journal of biochemical and molecular toxicology.

[14]  Glenville Jones,et al.  Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1α,25-(OH)2D3-26,23-lactone , 2007, Proceedings of the National Academy of Sciences.

[15]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[16]  Stephen H. White,et al.  Membrane Protein Insertion: The Biology–Physics Nexus , 2007, The Journal of general physiology.

[17]  Glenville Jones,et al.  Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies. , 2007, Archives of biochemistry and biophysics.

[18]  R. Serda,et al.  Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function. , 2007, Archives of biochemistry and biophysics.

[19]  Andrea Brancale,et al.  Homology model of 1α,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): Active site architecture and ligand binding , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  Peter V Coveney,et al.  Monotopic enzymes and lipid bilayers: a comparative study. , 2007, Biochemistry.

[21]  Rebecca C Wade,et al.  The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.

[22]  A. Plotnikov,et al.  Structural analysis of CYP2R1 in complex with vitamin D3. , 2007, Journal of molecular biology.

[23]  D. Tobias,et al.  Self-induced docking site of a deeply embedded peripheral membrane protein. , 2007, Biophysical journal.

[24]  M. Nichols,et al.  CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer , 2006, International journal of cancer.

[25]  T. Poulos,et al.  Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis. , 2006, Biochemistry.

[26]  K. Inouye,et al.  Structure-Function Analysis of Vitamin D 24-Hydroxylase (CYP24A1) by Site-Directed Mutagenesis: Amino Acid Residues Responsible for Species-Based Difference of CYP24A1 between Humans and Rats , 2006, Molecular Pharmacology.

[27]  J. Schmid,et al.  Selective inhibitors of vitamin D metabolism--new concepts and perspectives. , 2006, Anticancer research.

[28]  R. Bernhardt,et al.  Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.

[29]  Glenville Jones,et al.  Promise of vitamin D analogues in the treatment of hyperproliferative conditions , 2006, Molecular Cancer Therapeutics.

[30]  E. Szczesna-Skorupa,et al.  Identification of membrane-contacting loops of the catalytic domain of cytochrome P450 2C2 by tryptophan fluorescence scanning. , 2006, Biochemistry.

[31]  N. Kagawa,et al.  Interaction between mitochondrial CYP27B1 and adrenodoxin: role of arginine 458 of mouse CYP27B1. , 2006, Biochemistry.

[32]  James R. Halpert,et al.  Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole , 2006, Journal of Biological Chemistry.

[33]  Andrei L. Lomize,et al.  OPM: Orientations of Proteins in Membranes database , 2006, Bioinform..

[34]  Frank Hannemann,et al.  The interaction domain of the redox protein adrenodoxin is mandatory for binding of the electron acceptor CYP11A1, but is not required for binding of the electron donor adrenodoxin reductase. , 2005, Biochemical and biophysical research communications.

[35]  G. Ansari,et al.  Phospholipids modify substrate binding and enzyme activity of human cytochrome P450 27A1 Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.M400300-JLR200 , 2004, Journal of Lipid Research.

[36]  J. Welsh.  Vitamin D and breast cancer: insights from animal models. , 2004, The American journal of clinical nutrition.

[37]  Glenville Jones,et al.  Enzymes involved in the activation and inactivation of vitamin D. , 2004, Trends in biochemical sciences.

[38]  P. Tuohimaa,et al.  The role of Vitamin D3 metabolism in prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  B. Kemper,et al.  Structural basis for the role in protein folding of conserved proline-rich regions in cytochromes P450. , 2004, Toxicology and applied pharmacology.

[40]  Eric F. Johnson,et al.  The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.

[41]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[42]  R. Stevens,et al.  Structural commonalities among integral membrane enzymes , 2004, FEBS letters.

[43]  M. Chiu,et al.  Rat cytochrome P450C24 (CYP24A1) and the role of F249 in substrate binding and catalytic activity. , 2004, Archives of biochemistry and biophysics.

[44]  N. Swamy,et al.  Affinity labeling of rat cytochrome P450C24 (CYP24) and identification of Ser57 as an active site residue , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[45]  Eric F. Johnson,et al.  The 2002 Bernard B. Brodie Award lecture: deciphering substrate recognition by drug-metabolizing cytochromes P450. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[46]  R. Estabrook,et al.  Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling. , 2002, Biochemistry.

[47]  Primoz Pristovsek,et al.  A new electron transport mechanism in mitochondrial steroid hydroxylase systems based on structural changes upon the reduction of adrenodoxin. , 2002, Biochemistry.

[48]  M. Campbell,et al.  Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways , 2001, Steroids.

[49]  K. Inouye,et al.  Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. , 2000, European journal of biochemistry.

[50]  U. Heinemann,et al.  Adrenodoxin: Structure, stability, and electron transfer properties , 2000, Proteins.

[51]  D E McRee,et al.  XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.

[52]  M. Waterman,et al.  An Additional Electrostatic Interaction between Adrenodoxin and P450c27 (CYP27A1) Results in Tighter Binding Than between Adrenodoxin and P450scc (CYP11A1)* , 1999, The Journal of Biological Chemistry.

[53]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[54]  D. Nelson.  Metazoan cytochrome P450 evolution. , 1998, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[55]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[56]  U. Bornscheuer,et al.  Branched Phosphatidylcholines Stimulate Activity of Cytochrome P450SCC (CYP11A1) in Phospholipid Vesicles by Enhancing Cholesterol Binding, Membrane Incorporation, and Protein Exchange* , 1998, The Journal of Biological Chemistry.

[57]  T. Poulos,et al.  The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.

[58]  Manuel G. Claros,et al.  TopPred II: an improved software for membrane protein structure predictions , 1994, Comput. Appl. Biosci..

[59]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[60]  O. Gotoh,et al.  Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.

[61]  H. Pols,et al.  Vitamin D , 1928, Calcified Tissue International.

[62]  A. Brancale,et al.  Homology model of 1alpha,25-dihydroxyvitamin D3 24-hydroxylase cytochrome P450 24A1 (CYP24A1): active site architecture and ligand binding. , 2007, The Journal of steroid biochemistry and molecular biology.

[63]  J. Behlke,et al.  Self-association of adrenodoxin studied by using analytical ultracentrifugation. , 2007, Biophysical chemistry.

[64]  Helmut Sigel,et al.  The ubiquitous roles of cytochrome P450 proteins , 2007 .

[65]  N. Kagawa,et al.  Metabolism of vitamin D3 by cytochromes P450. , 2005, Frontiers in bioscience : a journal and virtual library.

[66]  Eric F. Johnson.  Deciphering Substrate Recognition by Drug-Metabolizing Cyto-chromes P450 , 2003 .

[67]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[68]  H. Morris,et al.  Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. , 2002, Annual review of nutrition.

[69]  Eric F. Johnson,et al.  Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5. , 2002, Methods in Enzymology.

[70]  D E McRee,et al.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.

[71]  M. Waterman,et al.  The tertiary structure of full-length bovine adrenodoxin suggests functional dimers. , 2000, Archives of biochemistry and biophysics.

[72]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[73]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.

[74]  T. Steitz,et al.  Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. , 1986, Annual review of biophysics and biophysical chemistry.